| Title | Clinical Advances in Hematology and Oncology |
| Abbreviation | Clin. Adv. Hematol. Oncol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Medicine (miscellaneous) (Q3); Oncology (Q3); Hematology (Q4) |
| h-index | 45 |
| Overall Rank/Ranking | 18126 |
| SCImago Journal Rank (SJR) | 0.261 |
| Impact Score | 0.46 |
| Publisher | Millennium Medical Publishing, Inc. |
| Country | United States |
| ISSN | 15430790 |
| Best Quartile | Q3 |
| Coverage History | 2003-2025 |
Clinical Advances in Hematology and Oncology is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q3); Oncology (Q3); Hematology (Q4). It is published by Millennium Medical Publishing, Inc.. The overall rank of Clinical Advances in Hematology and Oncology is 18126. According to SCImago Journal Rank (SJR), this journal is ranked 0.261. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 45. The best quartile for this journal is Q3.
The ISSN of Clinical Advances in Hematology and Oncology journal is 15430790. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Clinical Advances in Hematology and Oncology is cited by a total of 170 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Clinical Advances in Hematology and Oncology is 0.46, which is computed in 2025 as per its definition. Clinical Advances in Hematology and Oncology IF is increased by a factor of 0.04 and approximate percentage change is 9.52% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Clinical Advances in Hematology and Oncology is 0.46. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.46 |
| 2023 | 0.42 |
| 2022 | 0.41 |
| 2021 | 0.52 |
| 2020 | 0.69 |
| 2019 | 0.49 |
| 2018 | 0.63 |
| 2017 | 0.62 |
| 2016 | 0.57 |
| 2015 | 0.55 |
| 2014 | 0.45 |
Clinical Advances in Hematology and Oncology has an h-index of 45. It means 45 articles of this journal have more than 45 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Clinical Advances in Hematology and Oncology is 15430790. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Clinical Advances in Hematology and Oncology is 18126. According to SCImago Journal Rank (SJR), this journal is ranked 0.261. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.261 |
| 2023 | 0.264 |
| 2022 | 0.337 |
| 2021 | 0.323 |
| 2020 | 0.414 |
| 2019 | 0.462 |
| 2018 | 0.588 |
| 2017 | 0.595 |
| 2016 | 0.376 |
| 2015 | 0.361 |
| 2014 | 0.289 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 18126 |
| 2023 | 16969 |
| 2022 | 14041 |
| 2021 | 14100 |
| 2020 | 11772 |
| 2019 | 10506 |
| 2018 | 8217 |
| 2017 | 7919 |
| 2016 | 11551 |
| 2015 | 11771 |
| 2014 | 13374 |
Clinical Advances in Hematology and Oncology is published by Millennium Medical Publishing, Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 2003-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Clinical Advances in Hematology and Oncology is Clin. Adv. Hematol. Oncol.. This abbreviation ('Clin. Adv. Hematol. Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Medicine (miscellaneous) (Q3); Oncology (Q3); Hematology (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Clinical Advances in Hematology and Oncology latest impact IF is 0.46. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 0.69 (2020) and 0.41 (2022), respectively, in the last 11 years. Moreover, its average IS is 0.53 in the previous 11 years.
The Clinical Advances in Hematology and Oncology has an SJR (SCImago Journal Rank) of 0.261, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.595 in 2017 and the lowest being 0.261 in 2024. Furthermore, the average SJR of the Clinical Advances in Hematology and Oncology over the previous 11-year period stands at 0.53.
The latest h-index of the Clinical Advances in Hematology and Oncology is 45.
The Clinical Advances in Hematology and Oncology is published by the Millennium Medical Publishing, Inc., with its country of publication being the United States.
The Clinical Advances in Hematology and Oncology is currently ranked 18126 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 7919 in 2017 and its lowest position of 18126 in 2024.
The standard ISO4 abbreviation for the Clinical Advances in Hematology and Oncology is Clin. Adv. Hematol. Oncol..
Clinical Advances in Hematology and Oncology is classified as a journal that the Millennium Medical Publishing, Inc. publishes.
The Clinical Advances in Hematology and Oncology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Clinical Advances in Hematology and Oncology is assigned the following International Standard Serial Numbers (ISSN): 15430790.
The best quartile for the Clinical Advances in Hematology and Oncology is Q3 (2024).
The Clinical Advances in Hematology and Oncology coverage history can be summarized as follows: 2003-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Historia | journal | 22470 | Universidade Estadual Paulista | 9 | 0.16 |
| Journal of Business Finance and Accounting | journal | 3244 | Wiley-Blackwell Publishing Ltd | 96 | 3.34 |
| Air and Space Power Journal (discontinued) | journal | 28397 | AU Press | 9 | 0.20 |
| Canadian Journal of Education | journal | 15557 | Canadian Society for the Study of Education (CSSE) | 46 | 0.80 |
| Transnational Corporations | journal | 13970 | UNCTAD United Nations Conference on Trade and Development | 30 | 1.63 |
| Genes and Nutrition | journal | 4763 | BioMed Central Ltd | 69 | 4.26 |
| Physics and Chemistry of the Earth | journal | 12927 | Pergamon Press Ltd. | 33 | 0.00 |
| Poljoprivreda | journal | 17375 | Faculty of Agriculture in Osijek | 16 | 1.31 |
| Brazilian Symposium of Computer Graphic and Image Processing | conference and proceedings | 24442 | IEEE Computer Society | 34 | 0.41 |
| International Journal of Ozone Therapy | journal | 26290 | Centauro SRL | 6 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.46 |
| 2023 | 0.42 |
| 2022 | 0.41 |
| 2021 | 0.52 |
| 2020 | 0.69 |
| 2019 | 0.49 |
| 2018 | 0.63 |
| 2017 | 0.62 |
| 2016 | 0.57 |
| 2015 | 0.55 |
| 2014 | 0.45 |
